AAP
VNDA icon

Arax Advisory Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Arax Advisory Partners’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.7K Buy
2,133
+945
+80% +$7.29K ﹤0.01% 2251
2025
Q4 		$10.5K Sell
1,188
-15,880
-93% -$87.4K ﹤0.01% 2443
2025
Q3 		$85.2K Buy
17,068
+16,447
+2,648% +$76.1K ﹤0.01% 1594
2025
Q2 		$2.93K Buy
+621
New +$2.71K ﹤0.01% 2431
2025
Q1 		– Sell
-9
Closed -$44 – 3061
2024
Q4 		$44 Sell
9
-1,918
-100% -$9.21K ﹤0.01% 2404
2024
Q3 		$9.04K Hold
1,927
– – ﹤0.01% 1462
2024
Q2 		$10.9K Buy
+1,927
New +$9.95K ﹤0.01% 1227

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return